These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 29770337)

  • 1.
    Lantos I; Endrész V; Virok DP; Szabó A; Lu X; Mosolygó T; Burián K
    Biomed Res Int; 2018; 2018():8325915. PubMed ID: 29770337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Murine Norovirus on Chlamydia pneumoniae-Accelerated Atherosclerosis in ApoE(-/-) Mice.
    Patil K; Campbell LA; Rosenfeld ME; Paik J; Brabb T; O'brien KD; Maggio-Price L; Hsu CC
    Comp Med; 2016; 66(3):188-96. PubMed ID: 27298243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chlamydia pneumoniae infection significantly exacerbates aortic atherosclerosis in an LDLR-/- mouse model within six months.
    Liu L; Hu H; Ji H; Murdin AD; Pierce GN; Zhong G
    Mol Cell Biochem; 2000 Dec; 215(1-2):123-8. PubMed ID: 11204447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defective VLDL metabolism and severe atherosclerosis in mice expressing human apolipoprotein E isoforms but lacking the LDL receptor.
    Knouff C; Briand O; Lestavel S; Clavey V; Altenburg M; Maeda N
    Biochim Biophys Acta; 2004 Aug; 1684(1-3):8-17. PubMed ID: 15450205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ApoE-dependent modulation of HDL and atherosclerosis by G2A in LDL receptor-deficient mice independent of bone marrow-derived cells.
    Parks BW; Srivastava R; Yu S; Kabarowski JH
    Arterioscler Thromb Vasc Biol; 2009 Apr; 29(4):539-47. PubMed ID: 19164809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic perivascular inoculation with Chlamydophila pneumoniae results in plaque formation in vivo.
    Engelmann MG; Redl CV; Pelisek J; Barz C; Heesemann J; Nikol S
    Lab Invest; 2006 May; 86(5):467-76. PubMed ID: 16550192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genital Chlamydia infection in hyperlipidemic mouse models exacerbates atherosclerosis.
    Nagarajan UM; Sikes JD; Burris RL; Jha R; Popovic B; Fraungruber P; Hennings L; Haggerty CL; Nagarajan S
    Atherosclerosis; 2019 Nov; 290():103-110. PubMed ID: 31604170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chlamydia pneumoniae infections augment atherosclerotic lesion formation: a role for serum amyloid P.
    Ezzahiri R; Stassen FR; Kurvers HR; Dolmans V; Kitslaar PJ; Bruggeman CA
    APMIS; 2006 Feb; 114(2):117-26. PubMed ID: 16519748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunization of Chlamydia pneumoniae (Cpn)-infected Apob(tm2Sgy)Ldlr(tm1Her)/J mice with a combined peptide of Cpn significantly reduces atherosclerotic lesion development.
    Xia M; Chen D; Endresz V; Faludi I; Szabo A; Gonczol E; Kakkar V; Lu X
    PLoS One; 2013; 8(12):e81056. PubMed ID: 24349031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic intermittent hypoxia exposure induces atherosclerosis in ApoE knockout mice: role of NF-κB p50.
    Fang G; Song D; Ye X; Mao SZ; Liu G; Liu SF
    Am J Pathol; 2012 Nov; 181(5):1530-9. PubMed ID: 22940439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chlamydia pneumoniae infection induces an unstable atherosclerotic plaque phenotype in LDL-receptor, ApoE double knockout mice.
    Ezzahiri R; Stassen FR; Kurvers HA; van Pul MM; Kitslaar PJ; Bruggeman CA
    Eur J Vasc Endovasc Surg; 2003 Jul; 26(1):88-95. PubMed ID: 12819654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chlamydia pneumoniae does not increase atherosclerosis in the aortic root of apolipoprotein E-deficient mice.
    Aalto-Setälä K; Laitinen K; Erkkilä L; Leinonen M; Jauhiainen M; Ehnholm C; Tamminen M; Puolakkainen M; Penttilä I; Saikku P
    Arterioscler Thromb Vasc Biol; 2001 Apr; 21(4):578-84. PubMed ID: 11304476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear factor E2-related factor 2 deficiency impairs atherosclerotic lesion development but promotes features of plaque instability in hypercholesterolaemic mice.
    Ruotsalainen AK; Lappalainen JP; Heiskanen E; Merentie M; Sihvola V; Näpänkangas J; Lottonen-Raikaslehto L; Kansanen E; Adinolfi S; Kaarniranta K; Ylä-Herttuala S; Jauhiainen M; Pirinen E; Levonen AL
    Cardiovasc Res; 2019 Jan; 115(1):243-254. PubMed ID: 29917052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adipocyte enhancer-binding protein 1 (AEBP1) (a novel macrophage proinflammatory mediator) overexpression promotes and ablation attenuates atherosclerosis in ApoE (-/-) and LDLR (-/-) mice.
    Bogachev O; Majdalawieh A; Pan X; Zhang L; Ro HS
    Mol Med; 2011; 17(9-10):1056-64. PubMed ID: 21687917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No effect of C-reactive protein on early atherosclerosis in LDLR-/- / human C-reactive protein transgenic mice.
    Torzewski M; Reifenberg K; Cheng F; Wiese E; Küpper I; Crain J; Lackner KJ; Bhakdi S
    Thromb Haemost; 2008 Jan; 99(1):196-201. PubMed ID: 18217154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum Amyloid A Facilitates Early Lesion Development in Ldlr-/- Mice.
    Krishack PA; Bhanvadia CV; Lukens J; Sontag TJ; De Beer MC; Getz GS; Reardon CA
    J Am Heart Assoc; 2015 Jul; 4(7):. PubMed ID: 26187995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted disruption of LDLR causes hypercholesterolemia and atherosclerosis in Yucatan miniature pigs.
    Davis BT; Wang XJ; Rohret JA; Struzynski JT; Merricks EP; Bellinger DA; Rohret FA; Nichols TC; Rogers CS
    PLoS One; 2014; 9(4):e93457. PubMed ID: 24691380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low carbohydrate, high protein diet promotes atherosclerosis in apolipoprotein E/low-density lipoprotein receptor double knockout mice (apoE/LDLR(-/-)).
    Kostogrys RB; Franczyk-Żarów M; Maślak E; Gajda M; Mateuszuk L; Jackson CL; Chłopicki S
    Atherosclerosis; 2012 Aug; 223(2):327-31. PubMed ID: 22771189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delivery of Chlamydia pneumoniae to the vessel wall aggravates atherosclerosis in LDLr-/- mice.
    Hauer AD; de Vos P; Peterse N; ten Cate H; van Berkel TJ; Stassen FR; Kuiper J
    Cardiovasc Res; 2006 Jan; 69(1):280-8. PubMed ID: 16112098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The capacity of group V sPLA2 to increase atherogenicity of ApoE-/- and LDLR-/- mouse LDL in vitro predicts its atherogenic role in vivo.
    Boyanovsky B; Zack M; Forrest K; Webb NR
    Arterioscler Thromb Vasc Biol; 2009 Apr; 29(4):532-8. PubMed ID: 19164803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.